Flavio Crippa
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2018
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.
Journal: La Radiologia medica
Published: November 08, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 07, 2017
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.
Journal: Leukemia research
Published: November 09, 2016
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure.
Journal: Clinical genitourinary cancer
Published: March 10, 2016
Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation.
Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation.
Journal: Clinical nuclear medicine
Published: February 26, 2016
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.
Journal: Investigational new drugs
Published: January 13, 2016
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
Journal: Annals of surgical oncology
Published: January 11, 2016
Staging and follow-up of high-grade malignant salivary gland tumours: The role of traditional versus functional imaging approaches - A review.
Journal: Oral oncology
Published: November 10, 2015
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas.
Journal: Neuro-oncology
Published: August 24, 2015
Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.
Journal: Clinical genitourinary cancer
Published: July 14, 2015
Last Updated: 09/26/2026